Detalles de la búsqueda
1.
Complete Screening of Exons 2, 3, and 4 of KRAS and NRAS Genes Reveals a Higher Number of Clinically Relevant Mutations than Food and Drug Administration Quantitative Polymerase Chain Reaction-Based Commercial Kits.
Rev Invest Clin
; 72(6): 337-343, 2020 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33053566
2.
Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus.
Front Pharmacol
; 9: 320, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29681852
3.
The Frequency and Type of K-RAS Mutations in Mexican Patients With Colorectal Cancer: A National Study.
Am J Clin Oncol
; 40(3): 274-276, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25333735
4.
Complete screening of exons 2, 3, and 4 of kras and nras genes reveals a higher number of clinically relevant mutations than food and drug administration quantitative polymerase chain reaction-based commercial kits
Rev. invest. clín
; 72(6): 337-343, Nov.-Dec. 2020. tab
Artículo
en Inglés
| LILACS | ID: biblio-1289728
Resultados
1 -
4
de 4
1
Próxima >
>>